After publication of the article [1] it was brought to our attention that the incorrect length of needle was used for one of the epinephrine auto-injectors (EAI), Jext ® . The length of the needle of the Jext ® 0.15 mg is not 15.7 mm as mentioned in the paper, but 13 mm. After correcting the needle length for Jext ® , the results of the study do not change aside for those involving Jext ® . The results of the primary outcome variable for Jext ® are now the same as the other high pressure EAIs (HPEAIs) and do not lead to intra-osseous injections 38% but 11% between 15 and 30 kg. This is the same risk as the Epipen ® and the Auvi-Q ® .
